Brief: Allarity Therapeutics Announces Thomas Jensen As Interim CEO
12/12/2023 11:01
Dec 12 (Reuters) - Allarity Therapeutics Inc ALLR.O :
* ALLARITY THERAPEUTICS ANNOUNCES THOMAS JENSEN AS INTERIM
CEO AND
APPOINTMENT OF JEREMY R. GRAFF, PHD AS KEY EXECUTIVE ADVISOR
* ALLARITY THERAPEUTICS INC - JAMES G. CULLEM IS NO LONGER
PRESIDENT AND CEO
Source text for Eikon: ID:nGNX7nSMnH
Further company coverage: ALLR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Allarity Therapeutics
See all newsBrief: Allarity Therapeutics Announces Strategic Capital Allocation For Filing Of Spac Registration Statement
Allarity Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Allarity Therapeutics Q2 loss narrows as expenses fall
Allarity Therapeutics Inc expected to post a loss of 25 cents a share - Earnings Preview
Brief: Allarity Therapeutics Announces The Grant Of Essential U.S. Patent For Its Stenoparib Drp® Companion Diagnostic